ea0046nets9 | Open clinical session | UKINETS2016
Tadman Mike
Background and aims: Long-acting somatostatin analogues (SAs) are an established treatment for functional symptoms of neuroendocrine tumours (NETs) and also for their known anti-tumour effect. Discussion with colleagues highlighted variations in their use in practice, surrounding test-dosing and treatment doses of SAs.Methods: In 2016 an electronic survey of SA use was undertaken to illuminate actual practice in the UK. Questions focused on test-dosing, ...